PDS Biotechnology Corporation (PDSB)
SG&A Expenses
$3.07B
TTM · Period ending: · USD
PDSB SG&A Expenses
Latest reported$3.07Bperiod ending
Latest reported$3.07Bperiod ending
PDSB TTM SG&A Expenses ($8.66M → $3.07B)
TTM SG&A Expenses
High-resolution chart · PNG
PDSB sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 3,073,119,085 | |
| 3,073,298,370 | |
| 12,518,129 | |
| 13,064,626 | |
| 12,875,667 | |
| 13,621,840 | |
| 13,740,544 | |
| 13,866,106 | |
| 14,562,470 | |
| 15,097,185 | |
| 15,282,450 | |
| 15,007,479 | |
| 13,862,530 | |
| 12,502,215 | |
| 12,241,394 | |
| 12,507,524 | |
| 12,855,640 | |
| 11,866,462 | |
| 10,184,771 | |
| 8,802,207 | |
| 7,374,096 | |
| 6,554,004 | |
| 6,745,736 | |
| 6,454,487 | |
| 7,677,273 | |
| 8,539,537 | |
| 10,617,589 | |
| 12,347,000 | |
| 12,565,000 | |
| 13,516,000 | |
| 14,292,000 | |
| 16,593,000 | |
| 17,296,000 | |
| 18,134,000 | |
| 17,654,000 | |
| 16,525,000 | |
| 16,087,000 | |
| 15,203,000 | |
| 14,687,000 | |
| 14,133,000 | |
| 12,558,000 | |
| 11,034,000 | |
| 8,659,000 | |
| 6,233,000 | |
| 5,397,000 |